FDA OIS/OMS merger
This article was originally published in The Gray Sheet
FDA device center's Office of Information Systems and Office of Management Services are likely to be merged, according to FDA staffers. Donald Sauer joined the device center in January as acting associate director for management and systems, overseeing OIS and OMS ("The Gray Sheet" Feb. 14, In Brief). Sauer took on the duties of the OMS acting director with the departure of Helen Winkle this summer ("The Gray Sheet" July 11, p. 24). A merged OIS/OMS entity would assist FDA in achieving the National Performance Review objectives of streamlining mid-level management, staffers note
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.